Abstract:
The invention related to a device for cultivating cells comprising: - a lower part comprising at least two lower compartments, a lower wall separating the two lower compartments, and a semi-porous membrane covering the lower compartments, the semi-porous membrane comprising an upper surface intended to receive the cells; - a first upper part and a second upper part intended to be fitted onto the lower part, in order to obtain selectively: - a first configuration of the device wherein the first upper part is fitted onto the lower part, the first upper part forming an upper compartment wherein a culture medium can flow, in order to apply shear stress to the cells; - a second configuration of the device wherein the second upper part is fitted onto the lower part, the second upper part comprising at least two upper compartments, a wall separating the two upper compartments, and injection openings for injecting a substance to be tested in each upper compartment, the wall of the second upper part facing the wall of the lower element and being in contact with the semi-porous membrane so as to prevent a leakage of the injected substance from an upper compartment to another.
Abstract:
The present invention relates to a polymer obtained from the polymerization of: (i) at least one monomer of formula (I) (CH 2 =CR 1 )CO-K (I) wherein: K represents 0-Z or NH-Z, Z representing (CR 2 R 3 ) m -CH 3 , (CH 2 -CH 2 -O) m -H, (CH 2 - CH 2 -O ) m -CH 3 , (CH 2 ) m -N R 4 R 5 with m representing an integer from 1 to 30; R 1 , R 2 , R 3 , R 4 and R 5 independently represent H or a C1 -C6 alkyl; and (ii) at least one bio-resorbable block copolymer cross-linker.
Abstract:
The present invention relates to a method for preparing a cyclodextrin polymer and/or a hydrophilic polymer emulsion having cyclodextrins as well as lipophilic compounds, the emulsions having a remarkable stability. In particular, the method includes: (i) adding a lipophilic compound into an aqueous solution of a cyclodextrin unit polymer or hydrophilic polymer having cyclodextrins; (ii) forming an emulsion from the mixture resulting from step (i). The invention also relates to the resulting emulsions, i.e. stabilized emulsions by a non-covalent and non-crystalline inclusion complex consisting of (i) a cyclodextrin unit polymer or a hydrophilic polymer having cyclodextrins and (ii) a lipophilic compound. The invention also relates to the use of said emulsions in the cosmetic, pharmaceutical and/or agri-food fields.
Abstract:
The invention relates to an in vitro method for detecting pulmonary arterial hypertension (PAHT), or the risk of developing PAHT, which includes determining the presence and/or amount of anti-tenascin C antibodies in a biological sample from a patient.
Abstract:
The present invention relates to electro-optical components having intersubband transitions by means of quantum confinement between two Group III nitride elements, typically by means of GaN/AIN. The invention also relates to devices or systems including such components, as well as to a method for manufacturing such a component. According to the invention, such a component (2) includes at least one active area (23) that includes at least two so-called outer barrier layers (BL0, BL3) surrounding one or more N-doped quantum well structures (QW1, QW2, QW3), and is characterized in that said quantum well structure(s) are each surrounded by two barrier areas (BL0, BL1, BL2, BL3) that are unintentionally doped at a thickness of at least five monoatomic layers.